(Q43674536)

25 November 2017

title

LDL-receptor gene mutations and the hypocholesterolemic response to statin therapy (English)

1 reference

25 November 2017

0 references

1 reference

Brorholt-Petersen JU

1

1 reference

25 November 2017

Jensen HK

2

1 reference

25 November 2017

Raungaard B

3

1 reference

25 November 2017

Gregersen N

4

1 reference

25 November 2017

Faergeman O

5

1 reference

25 November 2017

publication date

1 June 2001

1 reference

25 November 2017

1 reference

25 November 2017

volume

59

1 reference

25 November 2017

issue

6

1 reference

25 November 2017

page(s)

397-405

1 reference

Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Scientific Steering Committee on behalf of the Simon Broome Register Group

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590604.X

Update on low density lipoprotein receptor mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590604.X

Influence of specific mutations at the LDL-receptor gene locus on the response to simvastatin therapy in Afrikaner patients with heterozygous familial hypercholesterolaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590604.X

Low-density lipoprotein receptor genotype-dependent response to cholesterol lowering by combined pravastatin and cholestyramine in familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590604.X

Association of specific LDL receptor gene mutations with differential plasma lipoprotein response to simvastatin in young French Canadians with heterozygous familial hypercholesterolemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590604.X

The type of mutation in the low density lipoprotein receptor gene influences the cholesterol-lowering response of the HMG-CoA reductase inhibitor simvastatin in patients with heterozygous familial hypercholesterolaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590604.X

Heterozygous familial hypercholesterolaemia: the influence of the mutation type of the low-density-lipoprotein receptor gene and PvuII polymorphism of the normal allele on serum lipid levels and response to lovastatin treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590604.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590604.X

The Trp23-Stop and Trp66-Gly mutations in the LDL receptor gene: common causes of familial hypercholesterolemia in Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590604.X

Fluvastatin: a review of its pharmacology and use in the management of hypercholesterolaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590604.X

Effects of probucol on plasma lipids and lipoproteins in familial hypercholesterolemic patients with and without apolipoprotein E4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590604.X

Two common low density lipoprotein receptor gene mutations cause familial hypercholesterolemia in Afrikaners

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590604.X

Two mutant low-density-lipoprotein receptors in Afrikaners slowly processed to surface forms exhibiting rapid degradation or functional heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590604.X

Effects of ML-236B (Compactin) on Sterol Synthesis and Low Density Lipoprotein Receptor Activities in Fibroblasts of Patients with Homozygous Familial Hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590604.X

Common low-density lipoprotein receptor mutations in the French Canadian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590604.X

Finnish type of low density lipoprotein receptor gene mutation (FH-Helsinki) deletes exons encoding the carboxy-terminal part of the receptor and creates an internalization-defective phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590604.X

The familial hypercholesterolemia (FH)-North Karelia mutation of the low density lipoprotein receptor gene deletes seven nucleotides of exon 6 and is a common cause of FH in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590604.X

Genetic clues revise view of Japanese roots

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590604.X

mtDNA analysis reveals a major late Paleolithic population expansion from southwestern to northeastern Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590604.X

Molecular background of the Finnish disease heritage

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590604.X

Homozygous familial hypercholesterolemia among French Canadians in Québec Province

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590604.X

7 January 2021

Is responsiveness to lovastatin in familial hypercholesterolaemia heterozygotes influenced by the specific mutation in the low-density lipoprotein receptor gene?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590604.X

7 January 2021

Influence of genotype at the low density lipoprotein (LDL) receptor gene locus on the clinical phenotype and response to lipid-lowering drug therapy in heterozygous familial hypercholesterolaemia. The Familial Hypercholesterolaemia Regression Study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590604.X

7 January 2021

Functional characterization of two low density lipoprotein receptor gene mutations by fluorescence flow cytometric assessment of receptor activity in stimulated human T-lymphocytes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590604.X

7 January 2021

Genotyping compared with protein phenotyping of the common apolipoprotein E polymorphism

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590604.X

7 January 2021

Familial hypercholesterolemia and apolipoprotein E4

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590604.X

7 January 2021

Apolipoprotein E polymorphism and plasma cholesterol response to probucol

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590604.X

7 January 2021

Influence of apo E polymorphism on the response to simvastatin treatment in patients with heterozygous familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590604.X

7 January 2021

The response to lovastatin treatment in patients with heterozygous familial hypercholesterolemia is modulated by apolipoprotein E polymorphism

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590604.X

7 January 2021

Apolipoprotein E phenotypes in familial hypercholesterolaemia: importance for expression of disease and response to therapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590604.X

7 January 2021

Deletion in the gene for the low-density-lipoprotein receptor in a majority of French Canadians with familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590604.X

7 January 2021

Detection of allele-specific transcripts by the polymerase chain reaction (AST-PCR)

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590604.X

7 January 2021

10.1034/J.1399-0004.2001.590604.X

Identifiers

DOI

1 reference

25 November 2017

1 reference